Skip to content

Neuroimaging Research on Postherpetic Neuralgia

Neuroimaging Research on Postherpetic Neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115631
Enrollment
Unknown
Registered
2025-12-29
Start date
2025-12-31
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic Neuralgia

Interventions

Observation Group of Postherpetic neuralgia:None

Sponsors

Chengdu Fifth People's hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with herpes zoster (HZ) will be recruited and screened at the Fifth People's Hospital of Chengdu. The clinical diagnosis of HZ and PHN should follow the diagnostic criteria of Dermatology and Venereology and the International Association for the Study of Pain (IASP). At the same time, 30 healthy controls matched by age and gender were recruited. Inclusion criteria: 1. Meet the diagnostic criteria; 2. Age over 20 years old, gender not limited, Han ethnicity, right-handed. 3.PHN group: Persistent pain at the original site after herpes healing for more than 1 month, VAS score >=5; 4.HC Group: During the same period, the physical examination center recruited healthy volunteers who were matched in terms of gender, age, and physical condition. They had no chronic pain, major mental illness, neurological disorders, abnormal brain structure, history of alcohol or drug abuse, and no obvious cerebral infarction or significant head movement. 5. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria 1.History of malignant tumors, intracranial infections, epilepsy or cerebrovascular diseases; 2. Mental illness (HADS Anxiety/Depression Scale > 11 points); 3. Drug use or long-term (> 3 months) use of anesthetic, sedative or analgesic drugs; 4. History of diabetic neuropathy or spinal surgery; 5. MRI contraindications (claustrophobia, metal implants in the body). 6. Pregnant women, lactating women or those suspected of being pregnant; Note: Any patient who meets any of the above conditions will be excluded.

Design outcomes

Primary

MeasureTime frame
Brain image indicator;

Secondary

MeasureTime frame
Clinical scale score;

Countries

China

Contacts

Public ContactZhou Shuqin

Chengdu Fifth People's hospital

821907625@qq.com+86 28 8272 6018

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026